We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Autoliv
ALV
$8.76B
| $1.62M | 0.01% |
+22,932
| New | +$1.68M |
|
827
Host Hotels & Resorts
HST
$17.1B
| $1.61M | 0.01% |
88,428
-1,001,134
| -92% | -$18.9M |
|
|
NGD
828
DELISTED
New Gold Inc
NGD
| $1.61M | 0.01% |
1,661,258
+639,717
| +63% | +$508K |
|
829
Blackrock
BLK
$165B
| $1.6M | 0.01% |
3,414
-2,904
| -46% | -$1.31M |
|
830
Carvana
CVNA
$45.9B
| $1.6M | 0.01% |
+127,675
| New | +$1.64M |
|
|
SHOE
831
Shoe Station Group
SHOE
$410M
| $1.59M | 0.01% |
115,206
-122,164
| -51% | -$1.9M |
|
832
NXP Semiconductors
NXPI
$67.6B
| $1.58M | 0.01% |
16,219
+15,605
| +2,542% | +$1.51M |
|
833
Lithia Motors
LAD
$7.88B
| $1.58M | 0.01% |
+13,317
| New | +$1.47M |
|
|
TRVG
834
trivago
TRVG
$382M
| $1.57M | 0.01% |
74,813
-109,869
| -59% | -$2.24M |
|
835
Triumph Financial Inc
TFIN
$1.8B
| $1.56M | 0.01% |
+53,839
| New | +$1.61M |
|
|
PDLI
836
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.56M | 0.01% |
498,199
+455,193
| +1,058% | +$1.48M |
|
837
Healthcare Services Group
HCSG
$1.58B
| $1.56M | 0.01% |
+51,384
| New | +$1.7M |
|
838
Quanta Services
PWR
$93.1B
| $1.54M | 0.01% |
+40,274
| New | +$1.53M |
|
839
Illinois Tool Works
ITW
$81.9B
| $1.53M | 0.01% |
+10,173
| New | +$1.54M |
|
840
OptimizeRx
OPRX
$120M
| $1.53M | 0.01% |
94,769
+36,475
| +63% | +$493K |
|
841
Invesco
IVZ
$13.3B
| $1.53M | 0.01% |
74,950
+54,464
| +266% | +$1.13M |
|
842
Sterling Infrastructure
STRL
$19.5B
| $1.53M | 0.01% |
114,034
+32,661
| +40% | +$421K |
|
843
General Dynamics
GD
$105B
| $1.52M | 0.01% |
+8,379
| New | +$1.44M |
|
844
iRadimed
IRMD
$1.22B
| $1.52M | 0.01% |
74,416
+65,819
| +766% | +$1.55M |
|
845
TJX Companies
TJX
$173B
| $1.5M | 0.01% |
28,440
-747,252
| -96% | -$39.7M |
|
846
Cadiz
CDZI
$259M
| $1.5M | 0.01% |
133,556
+31,766
| +31% | +$324K |
|
847
B&G Foods
BGS
$291M
| $1.5M | 0.01% |
+72,215
| New | +$1.67M |
|
848
Petrobras
PBR
$116B
| $1.49M | 0.01% |
95,670
-65,876
| -41% | -$1M |
|
849
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $1.49M | 0.01% |
7,393
+7,037
| +1,977% | +$1.39M |
|
|
FOCS
850
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.48M | 0.01% |
54,296
-6,757
| -11% | -$220K |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.